- ISO 17025 lab-tested
- 99%+ purity
- Research use only
FOXO4-DRI 10mg
-
Processed as soon as payment clears
Packed and dispatched without delay.
-
Free shipping over €99.00 to most EU countries
-
Shipment protection included
Lost or damaged in transit? We send a replacement.
-
Discreet packaging
Plain parcel, no product names on the outside.
-
We accept
Secure checkout
- SEPA bank transfer
Independent lab results
Tested before it reaches your bench
Every batch is analysed by an independent, ISO 17025-accredited laboratory before release. The report shown here belongs to the batch now shipping, so what you read is what you receive.
Analiza Białek sp. z o.o.
ISO/IEC 17025 accredited
HPLC purity
99%
Release minimum: 99%
- Lot
- EP10/012026
- Tested
- July 2, 2026
- Measured
- 9.94 mg
- Report no.
- UY76H13F
- Batch-specific
- Independent lab
Quality control results
1 passed · 1 reported-
Purity
Reversed-phase HPLC
99% Pass -
Net peptide content
HPLC quantitation
9.94 mg Reported
Tests in our panel
- Visual inspection · Colour, form and integrity of the lyophilised powder and the vial seal, checked against the specification.
- LC-MS · Confirms the molecular mass matches the expected structure of the compound.
- Impurity profile · Checks for residues from synthesis and handling that should not be present.
- Elemental analysis · Screens for toxic metals that can enter through raw materials or equipment.
- Microbial culture · Checks a sample for bacterial and fungal growth.
- Endotoxin assay · Measures bacterial endotoxins, reported in endotoxin units (EU) per vial.
All published batches
Every lot of this product we have released, each with its own certificate. Newest first.
FOXO4-DRI 10mg
LatestLOT EP10/012026
99%
HPLC purity
- Measured content
- 9.94 mg
- Tested on
- July 2, 2026
2 assays by Analiza Białek sp. z o.o.
Open certificateTechnical specifications
Compound at a glance
Molecular profile
FOXO4-DRI 10mg
- Compound class
- FOXO4-p53 interaction inhibitor (D-retro-inverso peptide)
- Research area
- Senolytic research
Handling
Storage and stability
- −20 °C as powder
- 2–8 °C in solution
- Protect from light
- Keep dry
Lyophilised powder
−20 °C, protected from light and moisture
In solution
2 to 8 °C
General guidance for laboratory storage. Follow your institution’s handling procedures.
About this compound
FOXO4-DRI 10 mg - Senolytic Peptide for Cellular Aging & Longevity Research
- Composition: 10 mg FOXO4-DRI (lyophilized peptide powder)
- Category: Peptide
- Form: Vial with freeze-dried powder
What is FOXO4-DRI?
FOXO4-DRI is a synthetic senolytic peptide developed for research into cellular senescence, aging pathways, and tissue homeostasis. It is mainly studied for its ability to interfere with the FOXO4-p53 interaction, a pathway associated with the survival of senescent cells.
In preclinical research, FOXO4-DRI is often investigated for its potential relevance in senescent cell clearance, cellular renewal, and age-related biological processes , making it a valuable compound for exploring longevity, tissue function, and cellular health.
Ideal for researchers investigating senescence pathways, FOXO4-p53 signaling, and cellular aging mechanisms.
Key Research Findings
Senescent Cell Research: Studied for its role in targeting senescent cells and supporting research into cellular renewal and tissue function.
FOXO4-p53 Pathway: Investigated for its ability to influence FOXO4 and p53 signaling , a pathway connected to cell cycle control and apoptosis.
Longevity Research: Relevant in studies focused on biological aging and age-related cellular decline in experimental models.
Tissue Homeostasis: Commonly studied in relation to cellular stress response, apoptosis regulation and tissue maintenance.
Storage Instructions
- Store at 2-8°C (36-46°F)
- Protect from light and moisture
- Avoid repeated freezing or temperature fluctuations
Why Choose FOXO4-DRI?
Among senolytic research peptides, FOXO4-DRI stands out for its targeted senescence research profile , combined with FOXO4-p53 pathway relevance and longevity-focused research potential.
Its unique mechanism of interest and broad research potential make it a key compound in studies of cellular senescence, longevity, and age-related pathways.
Order FOXO4-DRI 10 mg and explore its potential in advanced senescence and longevity research.
Research notice
For laboratory research use only. This product is not a medicinal product or a food. It is not intended for human or veterinary use, or for any diagnostic or therapeutic purpose.
The buyer is responsible for receiving, storing, handling and disposing of this material safely and lawfully, in line with the rules of their country and institution. We sell only to adults aged 18 or over who are qualified to work with research materials.
Descriptions on this page summarise published research for educational purposes. They are not medical advice and make no claim about safety or effects in humans.
